Understanding IBA's Capital Structure
IBA (Ion Beam Applications S.A.) is a pioneering company in the field of particle accelerator technology. As a leading supplier of equipment and services for proton therapy, IBA plays a vital role in advancing the most sophisticated forms of radiation therapy available. Their commitment to innovation is not only evident in their exceptional product offerings but also in how they manage their capital and shareholder voting rights.
Current Voting Rights and Capital Information
In accordance with regulations concerning the disclosure of major holdings, it is essential for IBA to keep its stakeholders informed about its total capital and voting rights. As of the latest update, IBA's total capital stands at 42,502,318.54 EUR. This capital is divided among various categories of securities, which hold significant weight for both regulatory compliance and investor awareness.
Nature and Amount of Voting Rights
Under current provisions, IBA has a total of 30,282,218 securities that confer voting rights. This figure forms the basis for calculating the thresholds established under the takeover law. Notably, these securities are crucial for determining how many votes a shareholder can exercise in meetings and product decisions.
Details on Loyalty Voting Rights
Shares that have been recorded in the share register for two consecutive years qualify for loyalty voting rights, enhancing the shareholders’ influence. This policy aligns with IBA's commitment to fostering long-term relationships with its investors.
Calculating Existing Voting Rights
From the total amount of shares with voting rights, IBA computes what is termed the existing voting rights. This figure currently stands at 40,516,629, incorporating loyalty shares into the equation to provide a comprehensive view of the voting landscape within the company. This calculation plays a vital role in maintaining transparency concerning shareholder influence.
Investor Communication Practices
IBA is devoted to ensuring that shareholders are kept informed through regular updates on the total capital and voting rights. The process includes timely communication regarding any changes to the number of securities with voting rights or any convertible bonds issued, which ensures adherence to the Belgian law governing public companies.
Contact and Reporting Obligations
For any threshold crossing notifications and shareholder inquiries, stakeholders are encouraged to reach out to the contact person provided on IBA’s communications. This proactive approach ensures open lines of dialogue between the company and its investors.
Governance and Future Outlook
With a solid governance structure, IBA is positioned to maintain its leadership in the particle accelerator sector. The company employs around 2,100 professionals across the globe, all of whom contribute to its mission of providing world-class healthcare solutions. Additionally, IBA's status as a certified B Corporation underscores its dedication to social and environmental performance.
Frequently Asked Questions
What is IBA's total capital as of now?
IBA's current total capital is 42,502,318.54 EUR.
How many securities confer voting rights at IBA?
IBA has a total of 30,282,218 securities that confer voting rights.
What are loyalty voting rights at IBA?
These are voting rights given to registered shares held for at least two consecutive years, enhancing investor influence.
How does IBA calculate existing voting rights?
Existing voting rights are calculated as 40,516,629, which includes the loyalty voting rights.
Who can shareholders contact for queries regarding voting rights?
Shareholders can reach out to shareholderrelations@iba-group.com for any inquiries.
